Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia

QR Code

Review of risperidone for the treatment of pediatric and adolescent bipolar disorder and schizophrenia

Jeffrey R Bishop1,2, Mani N Pavuluri21Department of Pharmacy Practice, University of Illinois at Chicago College of Pharmacy, Chicago, IL, USA; 2Department of Psychiatry, Pediatric Mood Disorders Program and Center for Cognitive Medicine, University of Illinois at Chicago College of Medicine, Chicag...

Description complète

Enregistré dans:

Détails bibliographiques
Auteurs principaux:	Jeffrey R Bishop, Mani N Pavuluri
Format:	article
Langue:	EN
Publié:	Dove Medical Press 2008
Sujets:	Neurosciences. Biological psychiatry. Neuropsychiatry RC321-571 Neurology. Diseases of the nervous system RC346-429
Accès en ligne:	https://doaj.org/article/114fb8b9e4014c84a4a5f1d80a3208a2
Tags:	Ajouter un tag Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires

Risperidone treatment for ADHD in children and adolescents with bipolar disorder
par: Joseph Biederman, et autres
Publié: (2008)

Comparison of somnolence associated with asenapine, olanzapine, risperidone, and haloperidol relative to placebo in patients with schizophrenia or bipolar disorder
par: Gao K, et autres
Publié: (2013)

Risperidone in the treatment of behavioral disorders associated with autism in children and adolescents
par: Roberto Canitano, et autres
Publié: (2008)

Emerging treatments in the management of bipolar disorder &ndash; focus on risperidone long acting injection
par: Wissam El-Hage, et autres
Publié: (2010)

Olanzapine approved for the acute treatment of schizophrenia or manic/mixed episodes associated with bipolar I disorder in adolescent patients
par: Ann E Maloney, et autres
Publié: (2010)

Hyperprolactinemia in Thai children and adolescents with autism spectrum disorder treated with risperidone
par: Hongkaew Y, et autres
Publié: (2015)

Clinical utility of the risperidone formulations in the management of schizophrenia
par: Madaan V, et autres
Publié: (2011)

Double-blind comparison of ziprasidone and risperidone in the treatment of Chinese patients with acute exacerbation of schizophrenia
par: Hongyan Zhang, et autres
Publié: (2011)

Combination treatment with risperidone long-acting injection and psychoeducational approaches for preventing relapse in schizophrenia
par: Zhao Y, et autres
Publié: (2013)

Asenapine monotherapy in the acute treatment of both schizophrenia and bipolar&nbsp;I disorder
par: Delia Bishara, et autres
Publié: (2009)

Sexual dysfunction in patients with schizophrenia treated with conventional antipsychotics or risperidone
par: Hong Liu-Seifert, et autres
Publié: (2009)

Paliperidone palmitate and risperidone long-acting injectable in subjects with schizophrenia recently treated with oral risperidone or other oral antipsychotics
par: Alphs L, et autres
Publié: (2013)

Update on extended release quetiapine fumarate in schizophrenia and bipolar disorders
par: El-Khalili N
Publié: (2012)

Differential diagnoses and management strategies in patients with schizophrenia and bipolar disorder
par: A Carlo Altamura, et autres
Publié: (2008)

Long-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia
par: Louz&atilde; M, et autres
Publié: (2011)

Association of Per3 length polymorphism with bipolar I disorder and schizophrenia
par: Karthikeyan R, et autres
Publié: (2014)

A validation of wrist actigraphy against polysomnography in patients with schizophrenia or bipolar disorder
par: Baandrup L, et autres
Publié: (2015)

Ziprasidone in the treatment of mania in bipolar disorder
par: Stephen E Nicolson, et autres
Publié: (2007)

Gabapentin adjunctive to risperidone or olanzapine in partially responsive schizophrenia: an open-label pilot study
par: Adel Gabriel
Publié: (2010)

Clinical outcomes of long-acting injectable risperidone in patients with schizophrenia: six-month follow-up from the Electronic Schizophrenia Treatment Adherence Registry in Latin America
par: Mario Louz&atilde;, et autres
Publié: (2010)

Adjunctive treatment with aripiprazole for risperidone-induced hyperprolactinemia
par: Ranjbar F, et autres
Publié: (2015)

The role of paliperidone extended release for the treatment of bipolar disorder
par: Marino J, et autres
Publié: (2012)

Early stages of pediatric bipolar disorder: retrospective analysis of a Czech inpatient sample
par: Goetz M, et autres
Publié: (2015)

Antipsychotic monotherapy among outpatients with schizophrenia treated with olanzapine or risperidone in Japan: a health care database analysis
par: Takahashi M, et autres
Publié: (2012)

Risperidone for children and adolescents with autism spectrum disorder: a systematic review
par: Maneeton N, et autres
Publié: (2018)

Facial expression in patients with bipolar disorder and schizophrenia in response to emotional stimuli: a partially shared cognitive and social deficit of the two disorders
par: Bersani G, et autres
Publié: (2013)

Possible new ways in the pharmacological treatment of bipolar disorder and comorbid alcoholism
par: Jean-Michel Azorin, et autres
Publié: (2010)

Update on quetiapine in the treatment of bipolar disorder: results from the BOLDER studies
par: Prashant Gajwani, et autres
Publié: (2007)

Long-term treatment of bipolar disorder with a radioelectric asymmetric conveyor
par: Mannu P, et autres
Publié: (2011)

Aripiprazole for the maintenance treatment of bipolar disorder: a review of available evidence
par: McIntyre R, et autres
Publié: (2011)

Increased expression of retinoic acid-induced gene 1 in the dorsolateral prefrontal cortex in schizophrenia, bipolar disorder, and major depression
par: Haybaeck J, et autres
Publié: (2015)

Differences in gray matter volume corresponding to delusion and hallucination in patients with schizophrenia compared with patients who have bipolar disorder
par: Song J, et autres
Publié: (2015)

The efficacy of Li in bipolar disorder
par: Lozano R, et autres
Publié: (2013)

Bipolar disorder and neurophysiologic mechanisms
par: Simon M McCrea
Publié: (2008)

The safety and effectiveness of open-label extended-release carbamazepine in the treatment of children and adolescents with bipolar I disorder suffering from a manic or mixed episode
par: Findling RL, et autres
Publié: (2014)

Treatment and prevention of mania in bipolar&nbsp;I disorder: focus on aripiprazole
par: David J Muzina
Publié: (2009)

The role of asenapine in the treatment of manic or mixed states associated with bipolar I disorder
par: Pompili M, et autres
Publié: (2011)

The role of ziprasidone in adjunctive use with lithium or valproate in maintenance treatment of bipolar disorder
par: Charles L Bowden
Publié: (2011)

New approaches for the management of bipolar disorder: role of sublingual asenapine in the treatment of mania
par: Warren CG, et autres
Publié: (2013)

Sodium valproate-induced enuresis in a pediatric bipolar patient
par: Cheng W, et autres
Publié: (2013)